Reported 4,000,000 shares, up 2,000,000 (100.0%) from the prior quarter.
Reported value 314.9%; share count 100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2020-03-31 | 2960000 |
| 2020-06-30 | 6980000 |
| 2020-09-30 | 28960000 |
| 2020-12-31 | 22960000 |
| 2021-03-31 | 18160000 |
| 2021-06-30 | 17440000 |
| 2021-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2021 | Reduced | 0 | -4,000,000 (-100.0%) | 0 | $0 | 2021-11-15 | |
| Q2 2021 | Unchanged | 4,000,000 | 0 (0.0%) | 0.62% | $17,440,000 | 2021-08-16 | |
| Q1 2021 | Unchanged | 4,000,000 | 0 (0.0%) | 0.62% | $18,160,000 | 2021-05-17 | |
| Q4 2020 | Unchanged | 4,000,000 | 0 (0.0%) | 0.74% | $22,960,000 | 2021-02-16 | |
| Q3 2020 | Added | 4,000,000 | +2,000,000 (100.0%) | 1.0% | $28,960,000 | 2020-11-16 | |
| Q2 2020 | Unchanged | 2,000,000 | 0 (0.0%) | 0.31% | $6,980,000 | 2020-08-14 | |
| Q1 2020 | Unchanged | 2,000,000 | 0 (0.0%) | 0.2% | $2,960,000 | 2020-05-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
135 managers reported CYMABAY THERAPEUTICS INC for Q3 2020.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | Added | 10,300,000 | +5,050,000 | 1.06% | $74,572,000 | 7 qtrs |
| BlackRock Inc | Reduced | 5,130,908 | -485,654 | < 0.01% | $37,147,000 | 15 qtrs |
| Boxer Capital LLC This report | Added | 4,000,000 | +2,000,000 | 1.0% | $28,960,000 | 15 qtrs |
| VANGUARD GROUP INC | Reduced | 3,373,119 | -7,256 | < 0.01% | $24,422,000 | 25 qtrs |
| BAKER BROS ADVISORS LP | Added | 3,252,542 | +1,729,750 | 0.09% | $23,548,000 | 2 qtrs |
| CITADEL ADVISORS LLC | Reduced | 2,221,555 | -478,543 | < 0.01% | $16,084,000 | 19 qtrs |
| Vivo Capital LLC | Unchanged | 2,089,356 | 0 | 0.87% | $15,127,000 | 3 qtrs |
| Invesco Ltd | Added | 1,877,586 | +1,781,858 | < 0.01% | $13,594,000 | 6 qtrs |
| Foresite Capital Management IV LLC | Reduced | 1,787,094 | -1,056,799 | 2.92% | $12,939,000 | 12 qtrs |
| Redmile Group LLC | Added | 1,719,247 | +44,800 | 0.23% | $12,447,000 | 13 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2020
- Filed
- November 16, 2020
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 4,000,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.